The lowering effect of ezetimibe on serum lipids and serum lipoprotein in postprandial hyperlipidemi
Not Applicable
- Conditions
- Type 2 diabetes mellitus with hyperlipidemia
- Registration Number
- JPRN-UMIN000013611
- Lead Sponsor
- akakinen clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1)Type 1 or secondary diabetes mellitus 2)With strong statin 3)With insulin 4)With Severe ketosis, diabetic coma or precoma 5)With any of myocardial infarction, angina pectoris, intracranial hemorrhage or cerebral infarction within 6 months 6)With moderate renal dysfunction(Serum CRE male:<1.4mg/dL, female:<1.2mg/dL) 7)With heart failure(HF) or history of HF 8)With severe hepatic dysfunction 9)With severe infection, perioperative period or severe injury 10)Patient who is pregnant, in lactation or suspected to be pregnant 11)Judged to be inadequate for including this study by PI or collaborators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The value of RLP-C 4 hour after fat loading test
- Secondary Outcome Measures
Name Time Method Value of serum lipid and AUC after fat loading test A value of blood glucose and AUC after fat loading test Changes in serum lipid during study period Changes in glycometabolism during study period Side effect